CERo Therapeutics (CEROW) Competitors $0.01 +0.00 (+35.35%) As of 06/12/2025 01:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock CEROW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CINGWShould you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry. CERo Therapeutics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity Cingulate CERo Therapeutics (NASDAQ:CEROW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, valuation and dividends. Does the media prefer CEROW or ATNFW? In the previous week, CERo Therapeutics had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for CERo Therapeutics and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat CERo Therapeutics' score of 1.43 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment CERo Therapeutics Positive 180 Life Sciences Very Positive Does the MarketBeat Community favor CEROW or ATNFW? CERo Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCERo TherapeuticsN/AN/A180 Life SciencesN/AN/A Which has stronger earnings & valuation, CEROW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCERo TherapeuticsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is CEROW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets CERo TherapeuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryCERo Therapeutics and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CEROW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CEROW vs. The Competition Export to ExcelMetricCERo TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$127.16M$5.61B$8.62BDividend YieldN/A3.74%5.28%4.17%P/E RatioN/A3.2927.2119.96Price / SalesN/A4,140.92408.49157.63Price / CashN/A13.1938.2534.64Price / BookN/A36.947.074.69Net IncomeN/A-$91.56M$3.23B$248.14M7 Day PerformanceN/A1.80%0.68%0.91%1 Month PerformanceN/A7.48%9.59%5.71%1 Year PerformanceN/A174.88%32.02%14.71% CERo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CEROWCERo TherapeuticsN/A$0.01+35.4%N/A-75.5%$0.00N/A0.008Negative NewsShort Interest ↓Gap DownATNFW180 Life SciencesN/A$0.01+8.5%N/A-50.6%$0.00N/A0.007Gap DownSXTPW60 Degrees PharmaceuticalsN/A$0.06-7.7%N/AN/A$0.00$665.45K0.002Gap DownDRTSWAlpha Tau MedicalN/A$0.23+9.0%N/A-2.0%$0.00N/A0.0080Gap UpWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.02+5.0%N/A+15.5%$0.00N/A0.0059Short Interest ↓Gap DownBCTXWBriaCell TherapeuticsN/A$0.09+19.5%N/A-81.4%$0.00N/A0.008Positive NewsShort Interest ↑Gap DownCDIOWCardio DiagnosticsN/A$0.02+1.9%N/A-63.3%$0.00$19.90K0.007Positive NewsShort Interest ↑Gap DownCTCXWCarmellN/A$0.03+6.8%N/A-67.0%$0.00$32.84K0.0014Gap UpCELUWCelularityN/A$0.05-5.4%N/A+102.4%$0.00$54.22M0.00220Gap UpCINGWCingulateN/A$0.05-4.9%N/A+117.1%$0.00N/A0.0020Positive News Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors WENAW Competitors APLMW Competitors BCTXW Competitors CDIOW Competitors CTCXW Competitors CELUW Competitors CINGW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CEROW) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CEROW Stock Free CEROW Stock Alerts